{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:13:34Z","timestamp":1794694414451,"version":"4.9.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Ankylosing spondylitis is an insidiously progressive and debilitating form of arthritis involving the axial skeleton. MicroRNAs have been reported to act as candidate biomarkers for ankylosing spondylitis diagnosis and progression. The study aimed to assess the roles of circulating miR\u2010146a and miR\u2010155 in ankylosing spondylitis and their prediction to clinical response to TNF\u2010\u03b1 blocking therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study included 62 ankylosing spondylitis patients who were given originator TNFi with a 6\u2010month period. Responders to anti\u2010TNF treatment were defined as those reaching the Assessment of SpondyloArthritis international Society 40 (ASAS40) response at the 6\u2010month interval, and nonresponders were defined those not (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The ankylosing spondylitis patients at M0 (before beginning TNFi treatment) had higher serum levels of miR\u2010146a and miR\u2010155 than the healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.0001). Lower serum levels of miR\u2010146a and miR\u2010155 were noted in the responders (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200938) compared with the nonresponders (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924) at different time points after anti\u2010TNF treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.0001). The serum levels of miR\u2010146a and miR\u2010155 alone or in combination used to predict treatment outcomes produced AUCs of 0.884, 0.902, and 0.936, respectively. We submitted the following variables: miR\u2010146a and miR\u2010155 levels, BASDAI, ASDASCRP, ESR (mm\/h), and CRP (mg\/L) into multivariate logistic regression analysis, and results showed that higher levels of miR\u2010146a (OR: 13.75, 95%CI: 1.32 to 143.57,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.029), miR\u2010155 (OR: 5.74, 95% CI: 1.63 to 20.20,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.006), and ESR (OR: 1.08, 95% CI: 1.01 to 1.15,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.022) were independent baseline predictors of ASAS40 response at 6\u2010month anti\u2010TNF\u2010a treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings obtained from the study suggest that high serum levels of miR\u2010146a and miR\u2010155 could aid in prediction of poor treatment outcomes after TNF\u2010\u03b1 blocking therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1756-185x.15004","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T03:21:18Z","timestamp":1703733678000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictive values of circulating miR\u2010146a and miR\u2010155 for disease activity and clinical response to TNF\u2010\u03b1 blocking therapy in patients with ankylosing spondylitis"],"prefix":"10.1111","volume":"27","author":[{"given":"Ling","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Rheumatology Jiujiang First People's Hospital  Jiangxi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-7965","authenticated-orcid":false,"given":"Xiaoyin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics Shanghai LiQun Hospital  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00838-z"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-022-01079-1"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221035"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223298"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.126714"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222608"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.05.044"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2020-0148"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna3030022"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00972-z"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000001339"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22266"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.32.4.324"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/1566523220666200916120708"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2018.10.012"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04825-6"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264558"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00408-z"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02650-4"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12089"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-018-0513-y"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4017-2"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez657"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13607"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-021-09249-6"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy008"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.11.067"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-08033-5"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000687"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24838"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3369"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.15004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.15004","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.15004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:57:49Z","timestamp":1786561069000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.15004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/1756-185X.15004"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.15004","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"2023-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15004"}}